The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Carnegie Mellon uses AFM to discover effects of experimental drugs on Alzheimer's plaques

PITTSBURGH - Scientists at Carnegie Mellon University have used atomic force microscopy (AFM) to shed light on molecular scale processes underlying the formation of insoluble plaques associated with Alzheimer's Disease. Results of this work suggest that AFM could lead to a better understanding of the disease process and help guide the search for new diagnostic and treatment approaches. The report will be published in the Jan. 23 issue of the Journal of Molecular Biology and appears online at http://www.sciencedirect.com/web-editions/journal/00222836.

Supported by the National Institutes of Health, the research was done in collaboration with scientists at Eli Lilly and Company and the Washington University School of Medicine. "Because AFM provides three-dimensional topographical information at the nanoscale, it could prove important in assessing the potential usefulness of molecules like antibodies to effectively inhibit protein aggregation associated with Alzheimer's Disease," said Tomasz Kowalewski, Ph.D., assistant professor of chemistry at Carnegie Mellon and senior author on the paper.

Alzheimer's Disease belongs to a class of disorders called conformational diseases, which are caused by changes in a protein's physical state. Another widely known example is prion-based 'Mad Cow' disease. Tools used to understand these disorders are targeted primarily to biochemical processes, noted Kowalewski, who works at the Mellon College of Science. "Because AFM probes the physical state of proteins, it could really assist in understanding conformational diseases, which traditionally have been difficult to fight," said Kowalewski.

A hallmark of Alzheimer's Disease is the presence of insoluble plaques in the brains of disease victims. These plaques are made of beta amyloid (A), a peptide derived from a precursor protein found in cell membranes. Once cleaved from its parent protein
'"/>

Contact: Lauren Ward
wardle@andrew.cmu.edu
412-268-7761
Carnegie Mellon University
20-Jan-2004


Page: 1 2 3

Related medicine news :

1. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
2. Carnegie Mellon University neurobiologist Justin Crowley receives Searle Scholar Award
3. Carnegie Mellon interactive-video DVD helps teens avoid sexually transmitted diseases
4. Carnegie Mellon statistics student honored for technique to aid in brain imaging
5. Acclaimed Carnegie Mellon psychologist honored for groundbreaking research
6. University of Pittsburgh, Carnegie Mellon University to share $10 million NIH grant to study mind-body relationships
7. Positive outlook, sense of self-control can predict new coronary events, says Carnegie Mellon study
8. Carnegie Mellon, Pitt Team Show That Adult Brains Compensate For Damage To Language Systems After Stroke Occurs
9. TB Alliance announces new drug discovery program with GlaxoSmithKline
10. Mayo Clinic discovers new pathway against pancreatic cancer
11. Newly discovered pathway might help in design of cancer drugs

Post Your Comments:
(Date:11/23/2009)...-FirstCall/-- ,, DearIsisSupportersandSharehold...ntinuingsupportofIsis.Webelieveweareatoneofthemost...thebeginningofcreatingauniquecompanywithanoveldrug...issueshauntingthepharmaceuticalindustry. ,, Our...shipdrug,mipomersen.Mipomersencontinuestoperformwe...
(Date:11/23/2009)...ylCompanies,thenation,sleadingproviderofoutsourced...edrecognitionasoneofthetopoutsourcingfirmsinhealth...magazine.Berylwasrankedamongthepublication,stop20o...hichenabledittoclimbfromtwelfthplacein2007totenthp...veproducts,suchasitsnewestlaunchofpost-dischargese...
(Date:11/23/2009)...rstCall/--ArcadiaResources,Inc.(NYSEAmex: KAD ),al...esundertheArcadiaHealthCare(SM)()brand,announcedto...haresofitscommonstockandwarrantstopurchasecommonst...nalinvestors,representinggrossproceedstoArcadiaofa...arateSubscriptionAgreementswiththeinvestors,Arcadi...
(Date:11/23/2009)...ascular Services, a division of Baptist Medical Ce...ddition of Aquapheresis Therapy using the Aquadex ...t of patients with fluid overload – helping ... Jackson, Miss. (Vocus) November 2...om fluid overload, time is of the essence. Excess ...
(Date:11/23/2009)...al,sDirectNutritionals,LLC,worldwidedistributorofD...siteCookieDiet.com( www.CookieDiet.com ),todayanno...pularhunger-satisfyingcookiesareavailableonSamsclu...,Sam,sClub. ,, "We,reproudtowelcomeSamsclub.com...l,sCookieDietproducts,andtheonlymembershipdiscount...
Breaking Medicine News(10 mins):Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:Arcadia Resources Announces Closing of $11.1 Million Financing 2Health News:Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment 2Health News:Baptist Cardiovascular Services Introduces New Technology for Congestive Heart Failure Treatment 3Health News:Dr. Siegal's COOKIE DIET(R) Cookies Available at Samsclub.com 2
(Date:11/20/2009)...ISBURG, Pa., Nov. 20 Th...H1N1 flu shots to members of priority groups that ... A total of 18 clinics are being held statewide on... to 8 p.m. Hours on Saturday, Nov. 21, will be 8 a... operate from 2 p.m. to 8 p.m. ,, Individuals ...
(Date:11/20/2009)...EW YORK, Nov. 20 ,, Reportlink... is available in its catalogue. ,, India Medic... ,, http://www.reportlinker.com/p0164658/Ind...-to-2015.html#utm_source=prnewswire&utm_medium...on ,, India Medical Equipment Market Analysis ...
(Date:11/20/2009)...CK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCal... today announced that it has received 510(k) clear...DA) and CE Mark approval to market its WallFlex...nt of malignant esophageal strictures (obstruction... non-resectable esophageal cancer. ,, (Photo: ...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 1Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 2Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 3Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 4Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 5Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 6Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 7Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 8Keryx Biopharmaceuticals Inc to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday August 6 2009 at 8 3A30am EDT 13361 1Keryx Biopharmaceuticals Inc to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday August 6 2009 at 8 3A30am EDT 13361 2ARUP Laboratories Applauds FDAs Decision on the Value of KRAS Mutation Testing in Colorectal Cancer 4822 1ARUP Laboratories Applauds FDAs Decision on the Value of KRAS Mutation Testing in Colorectal Cancer 4822 2ARUP Laboratories Applauds FDAs Decision on the Value of KRAS Mutation Testing in Colorectal Cancer 4822 3
Other News:
...ore older drivers give up their driving privileges...emselves asking, as it was in a popular film, "who...become a critical one as America ages, according t...o outlive their ability or willingness to drive ma...
...at emphasize staying at a certain weight are more ...ng behaviors to achieve their desired weight, a ne...so reveals risk factors that can be used to identi...gymnastics and ballet, who are particularly vulner...
...University of New York Upstate Medical University ...Francisco, have found evidence that methadone trea...ng tuberculosis (TB) preventive therapy to substan...ined with directly observed TB preventive therapy ...
...d adolescent drug use with health problems in earl...s who had used drugs as teens reported more health...lth problems included: increased incidence of resp...ions; cognitive problems, such as difficulty in co...
health news:Questions arise as more older Americans outlive driving privilege 2health news:Questions arise as more older Americans outlive driving privilege 3health news:Some sports linked to unhealthy eating behaviors in girls 2health news:Methadone treatment may improve completion of tuberculosis therapy in injection drug abusers 2
...study on the relationship between nonalcoholic fat...hat patients with an elevated level of the enzyme ...onary heart disease, which appears to be related t...ribution.......The results of this study appear in...
...N-SALEM, N.C. With a five-year, $1 million grant ...University Baptist Medical Center researcher will ...he developed for the most deadly type of brain tum...d a method to destroy cells of glioblastoma multif...
...ue 3-dimensional microscope that works in a new wa... internal structure and chemical composition. It i... by changes in temperature, humidity, weight load ...to advances in a range of areas, such as healthcar...
What: ...A new study, published in the Journal of the American Medical Association, found that the drug naltrexone, when used with specialized behavioral therapy can be an effective treatment for alc
health news:Patients with nonalcoholic fatty liver disease have an increased risk of heart disease 2health news:Scientist works to improve treatment for brain tumors 2health news:World-leading microscope shows more detail than ever 2health news:World-leading microscope shows more detail than ever 3health news:Media alert: Hazelden's chief medical director available to comment on drug treatment for alcoholics 2